Home » Topics » Regulatory

Regulatory
RSS

First FDA approval of naloxone nasal spray for opioid overdose

Nov. 19, 2015

FDA first to approve Darzalex for multiple myeloma

Nov. 17, 2015

Two Baxalta hemophilia A products approved in Europe, U.S.

Nov. 16, 2015

FDA approves Tagrisso to treat certain patients with NSCLC

Nov. 16, 2015

FDA approves label expansion for Harvoni

Nov. 13, 2015

FDA approves Genvoya single-tablet regimen for HIV-1

Nov. 6, 2015

Health Canada approves Cingal for osteoarthritis knee pain

Nov. 5, 2015

FDA first to approve GlaxoSmithKline's Nucala

Nov. 5, 2015

FDA approves Imlygic as first oncolytic viral therapy in U.S.

Oct. 28, 2015

FDA approves Belbuca buccal film for chronic pain

Oct. 28, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...